Accession Number: | 0001209191-21-040468 |
Date: | 2021-06-11 |
Issuer: | BIOLASE, INC (BIOL) |
Original Submission Date: |
BEAVER JOHN R
27042 TOWNE CENTRE DRIVE
SUITE 270
FOOTHILL RANCH, CA 92610
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNIT | 0.0 | 2021-06-11 | deemed execution date | A | 4,144,139 (a) | common stock 4,144,139 | $0.00 | 4,144,139 | direct |
ID | footnote |
---|---|
f1 | at the option of the company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent. |
f2 | the restricted stock unit award fully vests and is immediately exercisable upon the filing with the sec of the annual report on form 10-k for the year ending december 31, 2023, subject to performance-based vesting criteria as established by the compensation committee; provided that if the price of common stock on such vesting date is greater than $1.40 per share, one-half of the award amount above $1.40 shall be payable on the first anniversary of the vesting date, and one-half of such amount shall be payable on the second anniversary of the vesting date. |